All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

  1. [Antibiotics use in hospitals for acute pyelonephritis]

    KCE Reports 3 (2004)

    https://kce.fgov.be/en/antibiotics-use-in-hospitals-for-acute-pyelonephritis

  2. A decision aid for an informed choice when patient asks for PSA screening

    KCE Reports 224 (2014)

    https://kce.fgov.be/en/a-decision-aid-for-an-informed-choice-when-patient-asks-for-psa-screening

  3. A national clinical practice guideline on the management of localised prostate cancer - Part 1

    KCE Reports 194 (2013)

    https://kce.fgov.be/en/a-national-clinical-practice-guideline-on-the-management-of-localised-prostate-cancer-part-1

  4. Bladder cancer: an assessment of international practice guidelines

      KCE Reports 247 (2015) Bladder cancer: diagnosis and management - ‘This document was published by the National Collaborating Centre for Cancer in 2015 and commissioned by the National Institute for Health and Care Excellence (NICE). The original publication is available from http://www.nice.org.uk/guidance/ng2 NICE guidance is prepared for the National Health Service in England and Wales. NICE has not been involved in the development or adaptation of any guidance for use in Belgium.’  

    https://kce.fgov.be/en/bladder-cancer-an-assessment-of-international-practice-guidelines

  5. National practice guideline on the treatment of localised prostate cancer – part 2

    KCE Reports 226 (2014)

    https://kce.fgov.be/en/national-practice-guideline-on-the-treatment-of-localised-prostate-cancer-%E2%80%93-part-2

  6. Renal cancer in adults: diagnosis, treatment and follow-up

    KCE Reports 253 (2015)

    https://kce.fgov.be/en/renal-cancer-in-adults-diagnosis-treatment-and-follow-up

  7. The decisional process for the choice of active surveillance in localized prostate cancer

    KCE Reports 210 (2013)

    https://kce.fgov.be/en/the-decisional-process-for-the-choice-of-active-surveillance-in-localized-prostate-cancer